Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 309,031 | 276,472 | 314,993 | 521,917 | 542,513 |
| Marketable Securities | 2,037,750 | 1,710,397 | 1,666,670 | 1,499,910 | 1,509,880 |
| Receivables | 13,914 | 25,538 | 6,645 | 6,751 | 26,122 |
| Inventories | 22,200 | 22,033 | 20,645 | 19,811 | 24,032 |
| Other current assets | 159,724 | 168,254 | 143,173 | 142,759 | 150,577 |
| TOTAL | $2,542,619 | $2,202,694 | $2,152,126 | $2,191,148 | $2,253,124 |
| Non-Current Assets | |||||
| PPE Net | 85,158 | 74,294 | 180,806 | 177,015 | 177,724 |
| Intangibles | 0 | 0 | 29,605 | 29,054 | 29,295 |
| Other Non-Current Assets | 257,444 | 256,888 | 59,434 | 58,916 | 58,949 |
| TOTAL | $342,602 | $331,182 | $269,845 | $264,985 | $265,968 |
| Total Assets | $2,885,221 | $2,533,876 | $2,421,971 | $2,456,133 | $2,519,092 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,239 | N/A | 4,970 | 4,732 | 4,206 |
| Accounts payable and accrued liabilities | 10,499 | 17,921 | 20,545 | 10,351 | 16,125 |
| Accrued Expenses | 130,862 | 189,279 | 158,412 | 159,321 | 115,781 |
| Other current liabilities | N/A | 7,535 | N/A | N/A | N/A |
| TOTAL | $259,221 | $311,561 | $283,454 | $267,811 | $228,450 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 15,973 | 25,107 | 25,093 | 25,710 |
| Deferred Revenues | 92,335 | 90,577 | 99,511 | 93,393 | 91,437 |
| Other Non-Current Liabilities | 1,866,457 | 1,345,687 | 1,224,393 | 1,223,307 | 1,222,220 |
| TOTAL | $2,139,430 | $1,649,428 | $1,544,156 | $1,563,596 | $1,581,068 |
| Total Liabilities | $2,398,651 | $1,960,989 | $1,827,610 | $1,831,407 | $1,809,518 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,092 | 142,954 | 142,050 | 141,941 | 141,798 |
| Common Shares | 143 | 142 | 142 | 142 | 142 |
| Retained earnings | -1,553,948 | -1,429,625 | -1,377,195 | -1,330,203 | -1,225,068 |
| Other shareholders' equity | -48,983 | -57,480 | -63,140 | -54,007 | -48,578 |
| TOTAL | $486,570 | $572,887 | $594,361 | $624,726 | $709,574 |
| Total Liabilities And Equity | $2,885,221 | $2,533,876 | $2,421,971 | $2,456,133 | $2,519,092 |